Delivery Order SPE2DB24D2011-SPE2DB25FBQAY

Award Date 2/19/25
Potential Completion Date 2/20/25
Potential Value $3.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,364.06 firm fixed-price contract is for the supply of fluticasone-salmeterol 115-21 12GM, a respiratory medication, through January 31, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a federal Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,322.70, is for the supply of Fluticasone-Salmeterol 230-21 12GM, a pharmaceutical product used in medical care. The contract has a Period of Performance through July 25, 2024 and is a Firm Fixed Price agreement. This award is part of a larger Indefinite...
This is a $5,467.73 delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for the pharmaceutical product Fluticasone-Salmeterol 115-21 12GM, a critical medical supply. The contract has an ultimate completion date of August 8, 2024. AmerisourceBergen, a large pharmaceutical distributor, has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Fluticasone-Salmeterol 115-21 12GM, a respiratory medication. The contract has a ceiling value of $7,471.86 and an ultimate completion date of May 31, 2024. It is a firm-fixed-price contract and was not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $1,213.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of fluticasone-salmeterol 230-21 12GM, a pharmaceutical product, and has an ultimate completion date of January 14, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation. Amerisourcebergen holds a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $45,046.19 firm fixed-price delivery order is for the supply of fluticasone-salmeterol 230-21 12GM, a pharmaceutical product. The contract has an ultimate completion date of July 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,117.77 firm fixed-price delivery order is for fluticasone-salmeterol 230-21 12GM, a respiratory medication. The contract has an ultimate completion date of July 9, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,029.20 firm fixed price delivery order is for fluticasone-salmeterol 115-21 12GM, a pharmaceutical product. The contract has an ultimate completion date of January 24, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,413.56, is for the delivery of fluticasone-salmeterol 115-21 12GM, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of January 28, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,562.51 firm fixed-price delivery order is for the supply of fluticasone-salmeterol 115-21 12GM, a prescription medication. The contract has an ultimate completion date of February 7, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB24D2011
    Indefinite Delivery Contract
  • SPE2DB24D2011-SPE2DB25FBQAY
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of fluticasone-salmeterol 230-21 12GM medication. The contract has a firm fixed price of $3,429.83 and an ultimate completion date of February 20, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have a set-aside designation, indicating open competition.

Generated 5/22/25, 8:34 PM